KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Treasury Shares (2016 - 2025)

Neogenomics' Treasury Shares history spans 15 years, with the latest figure at $552208.0 for Q4 2025.

  • For Q4 2025, Treasury Shares fell 14.66% year-over-year to $552208.0; the TTM value through Dec 2025 reached $552208.0, down 14.66%, while the annual FY2025 figure was $552208.0, 14.66% down from the prior year.
  • Treasury Shares reached $552208.0 in Q4 2025 per NEO's latest filing, down from $3.0 million in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $3.0 million in Q3 2025 to a low of $305105.0 in Q2 2023.
  • Average Treasury Shares over 5 years is $1.1 million, with a median of $655427.5 recorded in 2024.
  • Peak YoY movement for Treasury Shares: tumbled 79.69% in 2023, then soared 366.55% in 2025.
  • A 5-year view of Treasury Shares shows it stood at $851403.0 in 2021, then soared by 134.3% to $2.0 million in 2022, then dropped by 1.65% to $2.0 million in 2023, then plummeted by 67.02% to $647084.0 in 2024, then dropped by 14.66% to $552208.0 in 2025.
  • Per Business Quant, the three most recent readings for NEO's Treasury Shares are $552208.0 (Q4 2025), $3.0 million (Q3 2025), and $588611.0 (Q2 2025).